Skip to content
Photos related to autism and the work of the IACC

Hearings and Testimony

Members from The Committee on Energy and Commerce at a hearing
February 14, 2024
The Committee on Energy and Commerce held a hearing to discuss legislation designed to support patients and caregivers.
Members of the he House Committee on Small Business including Congressman Marc Molinaro
January 30, 2024
The House Committee on Small Business held a subcommittee hearing in which members heard from witnesses about how entrepreneurs and employees with disabilities are strong contributors to the economy.
Autism Cares Act Hearing
June 25, 2019
The Subcommittee on Health held a legislative hearing to discuss the Autism CARES Act and three other bills under reauthorization.
Dr. Tom Insel Speaking
May 20, 2014
Dr. Insel provided an update on the Federal response to autism, including the work that has been done by the IACC.
Colleen Boyle and Alan Guttmacher
November 29, 2012
Domestic and advocacy group officials discussed efforts to increase autism awareness and understanding, the cost of the disease, and public health policy.
Tom Insel Testifying
July 11, 2011
The Subcommittee on Health held a hearing covering the bills H.R. 1852, Children's Hospital GME Support Reauthorization Act of 2011, and H.R. 2005, the Combating Autism Reauthorization Act of 2011. Summary.
Capital Hill Hearing at Senate Office Building
August 3, 2010
Environmental experts, researchers, and a parent of a child with autism testified on the state of research into the role of environmental factors in autism and neuro-development disorders.
Tom Insel testifying
August 5, 2009
A hearing was held on progress made since the subcommittee’s April 17, 2007 hearing on autism. Dr. Insel talked about autism research initiatives at the National Institutes of Health and various statistical analyses associated with research.
Hearing of the Senate Appropriates Subcommittee
April 17, 2007
Witnesses testified about the prevalence of autism and policy implications for health care in the U.S. Topics addressed included available treatments, research into the disease, and coordinating a federal response to the problem.
Back to Top